Multiple Sclerosis Relapse Rate Reduced By Nearly Half With Use of Two New Drugs - Wellsphere

Multiple Sclerosis Relapse Rate Reduced By Nearly Half With Use of Two New Drugs - Wellsphere: "Cladribine and fingolimod, two new oral drugs, have been shown to decrease the relapse rate in people who suffer from multiple sclerosis. The drugs could become the first treatments for the disease that does not require regular injections or infusions, if they gain approval by the U.S. Food and Drug Administration (FDA)."

Related articles by Zemanta

• Leukemia Risk from Multiple Sclerosis Drug May Be Up (nlm.nih.gov)